Cover Image
市場調查報告書

全球靜脈營養 (PN) 市場

Parenteral Nutrition

出版商 Global Industry Analysts, Inc. 商品編碼 210379
出版日期 內容資訊 英文 231 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球靜脈營養 (PN) 市場 Parenteral Nutrition
出版日期: 2015年02月01日 內容資訊: 英文 231 Pages
簡介

本報告提供全球靜脈營養 (PN) 市場相關調查分析,提供您包含各產品區隔,地區 (美國,加拿大,日本,歐洲,亞太地區,中東·非洲,南美等)之市場實際成果與預測,主要企業簡介等系統性資訊。

第1章 簡介,調查手法,產品定義

第2章 摘要整理

  • 產業概要
    • 靜脈營養 (PN)
    • 前途
    • 美國和歐洲
    • 最大市場
    • 全球市場集中
  • 市場趨勢·推動因素·問題點
    • 住院中的營養失調對策是臨床營養所不可或缺的
    • 劇增的高齡人口促進需求
    • 慢性疾病的劇增促進成長
    • 早產的劇增強化其必要性
    • 門診病人的靜脈內治療促進市場成長
    • 居家靜脈內營養治療的需求增加
    • 多腔式袋的選擇增加等
  • 產品概要
    • 靜脈內溶液:分析
    • PN:概要
  • 產品的銷售
  • 近來產業活動
  • 全球主要企業
    • Actavis, Inc. (美國)
    • Amanta Healthcare Ltd (印度)
    • B. Braun Melsungen AG (德國)
    • Baxter International, Inc. (美國)
    • Claris Lifesciences Limited (印度)
    • Fresenius KABI AG (德國)
    • Grifols International S.A. (西班牙)
    • Hospira, Inc. (美國)
    • 大塚製藥 (日本)
    • Sichuan Kelun Pharmaceutical Co., Ltd. (中國)
    • Sino-Swed Pharmaceutical Corp. Ltd. (中國)
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

第4章 競爭情形

  • 競爭企業簡介:25公司 (若包含產業部/子公司的話有31家公司)
    • 美國
    • 日本
    • 歐洲
    • 亞太地區 (日本以外)
    • 非洲

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7641

This report analyzes the worldwide markets for Parenteral Nutrition in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 25 companies including many key and niche players such as -

Actavis, Inc.
Amanta Healthcare Ltd.
B. Braun Melsungen AG
Baxter International, Inc.
Claris Lifesciences Limited

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Parenteral Nutrition - A Key Segment in Clinical Nutrition
  • The Road Ahead...
  • US and Europe, the Largest Markets
    • Table 1: World Parenteral Nutrition Market (2014): Percentage Share Breakdown of Value Sales by Geographic Region/Country (includes corresponding Graph/Chart)
    • Table 2: World Parenteral Nutrition Market (2014-2020): Growth Potential across Different Regional Markets (includes corresponding Graph/Chart)
  • The Large Markets Report Slight Slowdown in Y-O-Y Growth in 2013
    • Table 3: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 4: Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
  • A Concentrated Global PN Market...
    • Table 5: Global Market for Parenteral Nutrition by Leading Players (2013): Percentage Share Breakdown of Value Sales for B.Braun, Baxter International, Fresenius Kabi, Hospira and Others (includes corresponding Graph/Chart)
  • Select Parenteral Nutrition Products by Company

2. MARKET TRENDS, DRIVERS & ISSUES

  • Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
    • Table 6: Daily Requirements for Adults (Male and Female) by Nutrient Type
    • Table 7: Energy Requirements by Age and Gender (includes corresponding Graph/Chart)
    • Table 8: Protein and Vitamin Requirements by Gender
    • Table 9: Mineral Requirements by Gender and Mineral Type
  • Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
  • Opportunity Indicators:
    • Table 10: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 11: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 12: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
    • Table 13: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 14: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 15: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 16: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
  • Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
    • Table 17: Global Parenteral Nutrition Market by Disease Condition (2014): Percentage Share Breakdown of Number of Patients for Cancer, Crohn's Disease, Ulcerative Colitis, Motility Disorder, AIDS and Other Conditions (includes corresponding Graph/Chart)
  • Cancer Patients - the Highest PN Users
    • Table 18: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
    • Table 19: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 20: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 21: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 22: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 23: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 24: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 25: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 26: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 27: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
    • Table 28: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
    • Table 29: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
    • Table 30: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
  • Cancer Prone Sites based on Age
  • Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
  • Rising HIV Prevalence Provides Ample Growth Opportunities
    • Global HIV Statistics - Opportunity Indicators for Parenteral Nutrition
    • Table 31: Global Prevalence of HIV Infection Region in 2013 (in Millions) (includes corresponding Graph/Chart)
    • Table 32: Newly Infected HIV Population by Region in 2013 (in Thousands) (includes corresponding Graph/Chart)
    • Table 33: Global HIV Related Deaths in 2013 by Region (in Thousands) (includes corresponding Graph/Chart)
  • Diabetes Mellitus: Another Major Chronic Condition
    • Parental Nutrition Indicated for Diabetes Patients with Non-functional GI Tract
      • Global Diabetic Statistics - Opportunity Indicators
    • Table 34: Worldwide Prevalence of Diabetes Mellitus by Region (2014 & 2035) (includes corresponding Graph/Chart)
    • Table 35: Ten Countries with the Highest DM Cases (2014) (includes corresponding Graph/Chart)
    • Table 36: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in North America and Caribbean (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 37: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Europe (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 38: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in South-East Asia (2014): Breakdown by Country/Territory (in 000 People & %) (includes corresponding Graph/Chart)
    • Table 39: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Western Asia (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 40: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in South and Central America (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 41: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Middle East and North Africa (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 42: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Africa (2014): Breakdown by Country/Territory (in 000 People & %)
  • Rising Number of Premature Births Enhances Need for Parenteral Nutrition
  • Preterm Birth Statistics from WHO
    • Table 43: Percentage of Preterm Births by Region: 2012 (includes corresponding Graph/Chart)
    • Table 44: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart)
    • Table 45: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart)
  • Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market Growth
  • Growing Demand for Home Intravenous Nutritional Therapies
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
  • The Need for Low-Cost Solutions for Developing and Less-Developed Markets
  • Rising Popularity of Intravenous Vitamin C for Cancer Treatment
  • Increasing Demand for Peripheral Intravenous Nutrition
  • Iron Replacement Therapies - A Potential Market Segment
  • Continuous Supply of Raw Material: Crucial for Production
  • Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
  • Infection Control: A Prime Concern in IV Nutritional Therapy
  • Limiting Medication Errors - A Key Concern

3. PRODUCT OVERVIEW

  • Intravenous Solutions - An Insight
  • Intravenous Therapy
  • Intravenous Solutions
    • Tonicity and Osmolality
    • Production of IV Solutions
  • Types of IV Solutions
    • Colloid Solutions
    • Crystalloid Solutions
      • Properties of IV Solution Type Based on Concentration
      • Isotonic Crystalloids
      • Hypertonic Crystalloids
      • Hypotonic Crystalloids
    • Commonly Used Crystalloid Solutions
      • Saline Solution
      • Normal Saline
      • Half-Normal Saline
      • Quarter-Normal Saline
      • Hypertonic Saline
      • Dextrose
      • Saline with Additional Ingredients
      • Intravenous Sugar Solution
      • Dextrose Solutions or D5W
      • Other Types
    • Pre-mixed IV Solutions
    • Large and Small Volume Intravenous Solutions
    • Devices Used in IV Solutions Administration
  • Types of Intravenous Access Devices
    • Peripheral Cannula
    • Central IV Lines
    • Implantable Ports
    • Tunneled Lines
    • Peripherally Inserted Central Catheter (PICC)
  • IV Fluid Packaging
  • Possible Risks in Intravenous Therapy
    • Embolism
    • Electrolyte Imbalance
    • Extravasation/Infiltration
    • Phlebitis
    • Infection
  • Parenteral Nutrition - An Overview
  • An Introduction
  • Parenteral Nutrition Therapy
  • Sources of Parenteral Solutions
  • Routes of Administration
  • Types of Parenteral Nutrition Solutions
    • Total Parenteral Nutrition (TPN)
      • Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
      • Daily Recommended Parenteral Nutritional Intakes for Newborns
    • Partial Parenteral Nutrition (PPN)
    • Home Parenteral Nutrition
  • Central and Peripheral Parenteral Nutrition
  • Inpatient and Outpatient Environments
  • Parenteral Nutrition Formulations
    • Standard Solutions
      • Three-in-One Standard Bags
      • Two-in-one Standard Bags
      • Individual Solutions
      • Non-Standard Solutions
  • Classification of Parenteral Nutrition by Type of Nutrients
    • Amino Acids
    • Carbohydrates
    • Lipids
    • Minerals & Electrolytes
    • Micronutrients
    • Vitamins
    • Trace Elements
  • Large and Small Volume Parenteral Solutions
    • Large Volume Parenteral (LVP) Solutions
    • Small Volume Parenteral (SVP) Solutions
  • IV Fat Emulsions - Enabling Maintenance of Bodyweight
  • Regulatory Prerequisites

4. PRODUCT LAUNCHES

  • Kabi Introduces Kabiven® in the US
  • FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
  • Marck Biosciences Receives MCC Approval for Pharma Products
  • Baxter to Launch Plasma-Lyte A in India
  • Health Robotics to Unveil i.v.STATION® 2 for TPN
  • B. Braun Receives FDA approval for Large Volume PN Solutions
  • Claris Receives USFDA Approval for Marketing Products in the US
  • Taiho to Roll Out Aloxi® 0.75mg I.V Infusion Bag

5. RECENT INDUSTRY ACTIVITY

  • Aesynt™ Takes Over Health Robotics
  • Baxter to Create New Independent Biopharmaceutical Company
  • Hospira Recalls IV Electrolyte Solution
  • Becton, Dickinson and Company Takes over Cato Software Solutions
  • Baxter to Acquire Gambro AB
  • Otsuka Pharmaceutical Factory Forms a JV with Claris Lifesciences and Mitsui
  • B. Braun Establishes Pharmaceutical Plant in Fogelsville, US
  • Baxter International Completes Acquisition of SIGMA International
  • Aperture Health Takes Over Triad Therapeutics
  • Children's Hospitals and Clinics of Minnesota Deploys Cerner CareAwareiBusTM of CareFusion
  • Baxter Initiates Class I Recall of Automix Compounder

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Actavis, Inc. (US)
  • Amanta Healthcare Ltd (India)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (US)
  • Claris Lifesciences Limited (India)
  • Fresenius KABI AG (Germany)
  • Grifols International S.A. (Spain)
  • Hospira, Inc. (US)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)
  • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Sino-Swed Pharmaceutical Corp. Ltd. (China)

7. GLOBAL MARKET PERSPECTIVE

    • Table 46: World Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 47: World Historic Review for Parenteral Nutrition by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 48: World 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America Markets for the Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Rapidly Aging Demographics: A Major Driving Factor
    • Table 49: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
    • Rising Cancer Incidence Rate Drives Demand for Parenteral Nutrition
    • Table 50: New Cancer Cases in the US by Gender and Affected Site: 2014
    • Table 51: New Cancer Cases in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 52: New Cancer Cases in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 53: New Cancer Cases in US by State: 2014
    • Table 54: US Cancer Incidence for All Body Sites by Gender & Age Group (2013): New Cancer Cases for Males & Females for the Age groups Under 65 years; and 65 years and Above (includes corresponding Graph/Chart)
      • Cancer Mortality Statistics
    • Table 55: Cancer Related Deaths in the US by Gender and Body Site: 2014
    • Table 56: Cancer Related Deaths in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 57: Cancer Related Deaths in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 58: Number of Deaths Related to Major Types of Cancer in US by State: 2014
    • Prevalence of Diabetes Mellitus in the US - A Case for Parenteral Nutrition
    • Table 59: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in North America and Caribbean (2014): Breakdown by Country/Territory (in 000 People & %)
    • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
      • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
    • Medicare Coverage for Parenteral Nutrition Therapy
      • Reimbursement Regulations to Hamper Market Growth
      • A.S.P.E.N. Practice Guidelines for Parenteral Nutrition
      • A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004)
      • Impact of Patient Protection and Affordable Care Act on IV Solutions Market
    • Product Launches
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 60: US Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 61: US Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Cancer - A Business Case for Parenteral Nutrition Market
    • Table 62: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
    • Table 63: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 64: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Table 65: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
    • Table 66: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 67: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Diabetes Leads to Increase in GI Disorder Cases - Opportunity for PN
    • Table 68: Prevalence of Diabetes Mellitus in Canada: 2014
  • B. Market Analytics
    • Table 69: Canadian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: Canadian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Rising Cancer and Diabetes Cases Provide Growth Opportunity
    • Table 71: Cancer Related Deaths by Age Groups: 2013 (includes corresponding Graph/Chart)
    • Table 72: Prevalence of Diabetes Mellitus in Japan (2014)
    • Product Launch
    • Otsuka Pharmaceutical Factory, Inc. - A Major Player
  • B. Market Analytics
    • Table 73: Japanese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Japanese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Aging Population & Rising Incidence of Chronic Diseases to Drive Growth
      • Aging Statistics
    • Table 75: Population Breakup by Age Group for Select European Countries: 2012 (as a Percentage of Total Population) (includes corresponding Graph/Chart)
      • Cancer and Diabetes Mellitus in Europe: Key Statistics
    • Table 76: European Predicted Cancer Deaths in 2014: Number of Deaths by Gender and Major Cancer Type (includes corresponding Graph/Chart)
    • Table 77: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Europe by Country/Territory (2014) (In 000 People & %)
  • B. Market Analytics
    • Table 78: European Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 79: European Historic Review for Parenteral Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 80: European 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for the Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 81: French Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 82: French Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Select Players
  • B. Market Analytics
    • Table 83: German Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: German Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 85: Italian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 86: Italian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analysis
    • Table 87: UK Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 88: UK Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Grifols International S.A. - A Key Player
  • B. Market Analytics
    • Table 89: Spanish Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Spanish Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 91: Russian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 92: Russian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)
  • 4G. REST OF EUROPE
  • A. Market Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 93: Rest of European Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 94: Rest of European Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Diabetes and HIV Statistics in Asia-Pacific
    • Table 95: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Southeast Asia (2014): Breakdown by Country/Territory (in 000 People & %) (includes corresponding Graph/Chart)
    • Table 96: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Western Asia by Country/Territory (2014) (In 000s & %)
    • Table 97: Incidence of Type 1 Diabetes in Children by Select Countries in Western Pacific (2012) (includes corresponding Graph/Chart)
    • Table 98: Top 12 Countries in Asia-Pacific with Highest HIV Incidence (2012) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 99: Asia-Pacific Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 100: Asia-Pacific Historic Review for Parenteral Nutrition by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 101: Asia-Pacific 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, China and Rest of Asia-Pacific Markets for the Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5a. AUSTRALIA

  • Market Analysis
    • Table 102: Australian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 103: Australian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

5b. CHINA

  • A. Market Analysis
    • Outlook
    • Select Players
  • B. Market Analytics
    • Table 104: Chinese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 105: Chinese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

5c. INDIA

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 106: India Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 107: India Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

5d. REST OF ASIA-PACIFIC

  • Market Analysis
    • Table 108: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 109: Rest of Asia-Pacific Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

6. MIDDLE EAST/AFRICA

  • A. Market Analysis
    • Increasing Incidence of Chronic Conditions: Opportunity for PN Market
    • Diabetes Prevalence Statistics
    • Table 110: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Africa (2014): Breakdown by Country/Territory (in 000 People & %)
    • Table 111: Prevalence of Diabetes Mellitus in Middle East & North Africa (2014): Breakdown by Country/Territory and Age Group (in 000 People & %) (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Table 112: Middle East/Africa Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 113: Middle East/Africa Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Diabetes in Latin America - Opportunity Indicator
    • Table 114: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Breakdown by Country and Age Group (In 000 People & %)
  • B. Market Analytics
    • Table 115: Latin America Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 116: Latin America Historic Review for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 117: Latin America 14-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for the Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top